文献速递神经肿瘤

脑室内转移瘤的立体定向放射外科治疗:一项多中心研究

Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study.
PubMed 文献 · Neurosurgery · 2022-12-07

这项回顾性多中心研究纳入11个中心160例接受立体定向放射外科(SRS)治疗的脑室内转移瘤(IVM)患者,共治疗1045个颅内转移灶,其中196个为IVM;SRS后中位生存10个月,12个月和24个月局部IVM控制率分别为91.4%和86.1%,16例(10%)出现脑积水、27例(17.5%)出现软脑膜播散,作者认为SRS是IVM的有效治疗选择,但需密切随访以发现软脑膜播散和脑积水。

要点

  • SRS治疗IVM的12个月和24个月局部控制率分别为91.4%和86.1%。
  • SRS后16例(10%)发生脑积水,27例(17.5%)发生软脑膜播散。
  • SRS后中位生存10个月,11例(6.9%)死于颅内疾病进展。

核心结论

  • SRS是IVM的有效治疗选择,其局部IVM控制率与实质脑转移瘤的SRS相当。
  • IVM患者中软脑膜播散和脑积水仅发生于少数患者,但作者认为这些患者需要仔细随访以发现这些变化。

研究设计与样本

  • 回顾性、多中心研究,纳入11个中心160例接受SRS治疗的IVM患者。
  • 共治疗1045个颅内转移灶,其中196个为IVM。
  • 记录SRS所致不良事件、局部肿瘤或颅内进展、新发脑积水或软脑膜播散的频率,并分析患者神经影像或临床结局相关变量。

主要发现

  • SRS后中位生存10个月。
  • 在154例患者和190个IVM有影像随访中,94例患者(61%)出现远处颅内疾病进展,16个IVM(8.4%)局部进展。
  • 12个月和24个月局部IVM控制率分别为91.4%和86.1%。
  • 16例(10%)患者SRS后发生脑积水,27例(17.5%)发生软脑膜播散。
  • 24例患者(15%)记录到放射不良反应;11例患者(6.9%)死于颅内疾病进展。

临床怎么用

  • 作者认为SRS是IVM的有效治疗选择,其局部IVM控制率与实质脑转移瘤的SRS相当。
  • 作者认为IVM患者中软脑膜播散和脑积水发生于少数患者,但这些患者需要仔细随访以发现这些变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraventricular metastases (IVMs) are uncommon, and their optimal management remains debatable. OBJECTIVE: To define the safety and efficacy of stereotactic radiosurgery (SRS) in the treatment of IVMs. METHODS: This retrospective, multicenter study included patients managed with SRS for IVMs. SRS-induced adverse events, local tumor or intracranial progression, and the frequency of new-onset hydrocephalus or leptomeningeal spread were documented. Analyses of variables related to patient neuroimaging or clinical outcomes were also performed. RESULTS: The cohort included 160 patients from 11 centers who underwent SRS for treatment of 1045 intracranial metastases, of which 196 were IVMs. The median survival from SRS was 10 months. Of the 154 patients and 190 IVMs with imaging follow-up, 94 patients (61%) experienced distant intracranial disease progression and 16 IVMs (8.4%) progressed locally. The 12- and 24-month local IVM control rates were 91.4% and 86.1%, respectively. Sixteen (10%) and 27 (17.5%) patients developed hydrocephalus and leptomeningeal dissemination post-SRS, respectively. Adverse radiation effects were documented in 24 patients (15%). Eleven patients (6.9%) died because of intracranial disease progression. CONCLUSION: SRS is an effective treatment option for IVMs, with a local IVM control rate comparable with SRS for parenchymal brain metastases. Leptomeningeal spread and hydrocephalus in patients with IVM occur in a minority of patients, but these patients warrant careful follow-up to detect these changes.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Mantziaris G, Pikis S, Xu Z, et al. Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study. Neurosurgery. 2022. PMID: 36512817. doi:10.1227/neu.0000000000002248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。